Release Date: May 30, 2025
Expiration Date: May 30, 2026
Activity Overview
This online, on-demand virtual symposium brings together renowned experts in small cell lung cancer (SCLC). In this educational program, these experts provide an update on available and emerging treatment approaches for unresectable SCLC. Case scenarios highlight the practical challenges of using novel treatment options, particularly T cell–engaging approaches. Key considerations for selecting treatment and preventing and managing adverse events are also discussed.
This educational activity is an archive of the live symposium held on April 11, 2025.
Target Audience
This educational activity is directed toward oncology nurses, nurse practitioners, physician assistants, and oncologists who treat patients with SCLC.
Learning Objectives
Upon successful completion of this activity, you should be better prepared to:
- Describe the latest and emerging treatment options for SCLC, including immunotherapies, targeted agents, and chemotherapy regimens
- Implement strategies to mitigate and manage adverse events with SCLC therapies
- Identify effective communication strategies for counseling patients on their diagnosis, prognosis, and treatment options regarding SCLC
GET STARTED WITH THIS PROGRAM:
Register now to gain access to this program.
Create AccountAlready Registered? Login Here